Signed in as:
- TV and Media Reports
- H.E.L.P. Apheresis Blog
- Apheresis Center Videos
- Travel and Accommodation
- Patients Area Login
Signed in as:
The application of Intravenous Immunoglobulin (IVIG) and monoclonal antibodies (mABs) represents a new area in treating Long Covid, Post Vac and Chronic Illnesses. These conditions involve complex immune dysregulation and inflammatory responses.
IVIG is a concentrated preparation of immunoglobulins derived from pooled human plasma.
The current official indications include symptoms present in chronic illness and many post-viral conditions: Myo- and Pericarditis, Small Fiber Neuropathy but also acute/severe conditions like Sepsis.
Monoclonal antibodies, designed to target specific components of the immune response, present another avenue for intervention.
Both IVIG and mABs are being investigated for their potential to restore immune homeostasis.
Anecdotal note: mABs are designed strain-specific, IVIGs are not. To our knowledge there have been no reports of Long Covid/Post Vac patients worsening permanently after IVIG treatment, whereas with mABs there is a risk of side effects worsening a patient under certain circumstances.
The only patients our medical team has observed to worsen temporarily after IVIG treatment were patients with symptoms presenting similar to headaches expanding down to the neck area.
*services supplied by Akamantis Health
49 Eleftherias Avenue, Aradippou
7102 Larnaca, Cyprus
phone +357 24257400
whatsApp +357 24257400 (voice calls, video calls and text messages)
BOOK A FREE CONSULTATION - CLICK HERE
PATIENTS AREA LOGIN - CLICK HERE
We speak German, English and Greek
Apheresis Center is a brand of Raegal Management Limited
Our diagnostic screening questionnaire is used by patients and clinicians all over the world. It gives you an indication (it does not replace a clinical test) on how severely you are affected by microclots, microcirculation and blood flow issues and if further investigation is meaningful.